Загрузка...
ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
Estrogen receptor alpha gene (ESR1) fusion transcripts have been identified in breast cancer but their role in breast cancer is not completely understood. Here, we report a causal role for ESR1 fusions in driving both endocrine therapy resistance and metastasis, and describe a therapeutic strategy t...
Сохранить в:
| Опубликовано в: : | Mol Cell Oncol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276858/ https://ncbi.nlm.nih.gov/pubmed/30525098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1526005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|